Today, scientists still do not know the cause of Alzheimer’s disease (AD), yet decades of research advancements give hope to the possibility of slowing down early-onset of AD. Benfotiamine, a therapeutic drug that raises blood vitamin B1, levels very high, was recently tested as a pilot clinical study conducted by the Gibson Lab at the Burke Neurological Institute.
June is Alzheimer’s & Brain Awareness Month, and the Alzheimer’s Association Hudson Valley Chapter has a variety of educational and social programs available for the general public and for famili
Stroke affects over 795,000 people in the U.S. alone each year, that is one person every 40 seconds. Dr. Tomoko Kitago, lab director of the Human Motor Recovery Laboratory at the Burke Neurological Institute, talks about stroke awareness, treatments and the importance of clinical trials.
To conclude National Cerebral Palsy Awareness Month, the Cerebral Palsy Foundation announced with great honor, Dr. Kathleen Friel of the Burke Neurological Institute is the 2021 National Cerebral Palsy Awareness Research Award recipient.
A diagnosis of Parkinson’s Disease can be quite challenging for patients and their families. Since April is Parkinson’s Disease Awareness Month, it’s a perfect time to highlight the importance of exercise in reducing symptoms and improving quality of life in people living with PD.
We are very pleased to announce that Dr. David Gould will be joining the Burke Neurological Institute (BNI) as Chief Operating Officer starting in early April.
